ravenscroft apothecary, inc. – FDA Warning Letter, Mar 10, 2021
On March 12, 2021, the FDA and FTC issued a Warning Letter to Ravenscroft Escentials for selling unapproved and misbranded products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19. The agencies reviewed the company's websites, www.ravenscroftescentials.com and www.instagram.com/ravenscroftoils, on March 3 and March 10, 2021.
The products cited include "AIR PURIFY AROMAMIST," "HEALER’s CHAI AROMATEA & BREATH DROPS," "ELEVATION OF MIND AROMAMIST," and "ROSE FREQUENCY TONGUE TINCTURE." These products are considered unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) of the FD&C Act (21 U.S.C. § 331(a) and (d)).
Examples of violative claims include "CORONAVIRUS ESSENTIAL OILS," "Antiviral essential oils," and specific claims for Cinnamon Bark, Card
ID · df982f56-65d7-4ec2-ad4a-c5086458ec13
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.